Leslie Baumann is a Dermatology physician affiliated with Baumann Cosmetic Dermatology. OpenAlex indexes 255 publications with 4,488 citations (h-index 35); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 Biscayne Blvd
Suite 101
Miami, FL 33137
Telephone
305-532-5552Registry record last updated 1 May 2017.
Clinical trials
- Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler
Sponsor: Sofregen Medical, Inc.
- Open Label Study Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions
Sponsor: Baumann Cosmetic and Research Institute
- Lifting and Tightening of the Face and Neck Utilizing the Ulthera® System
Sponsor: Ulthera, Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- PFIZER INC.Program year20251 payment
- ABBVIE INC.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
52%Antifibrinolytic Agent52%Tranexamic Acid100%Part D<11 patientsMetabolism & gastrointestinal
48%GLP-1 receptor agonist48%Mounjaro100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Relevance of Elastin in the Structure and Function of Skin
Aesthetic Surgery Journal Open Forum
2021 - Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial
Journal of the American Academy of Dermatology
2020 - How to Use Oral and Topical Cosmeceuticals to Prevent and Treat Skin Aging
Facial Plastic Surgery Clinics of North America
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”